RADIOLABELLING OF NEUROTENSIN AGONIST AND ANTAGONIST WITH 177LU

被引：0
|
作者：
Lungu, Valeria [1 ]
Chiper, Diana [1 ]
Matei, Lidia [1 ]
Barna, Catalina [1 ]
Gruia, Iuliana [2 ]
Tuta, Catalin [1 ]
Postolache, Cristian [1 ]
Cimpeanu, Catalina [1 ]
机构：
[1] Horia Hulubei Natl Inst Phys & Nucl Engn, Magurele, Romania
[2] Alexandru Trestioreanu Inst Oncol, Bucharest, Romania
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2010年 / 53卷 / 5-6期
关键词：
Lu-177; DOTA; SR48692; radiolabelling; neurotensin; agonist; antagonist;
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：466 / 468
页数：3
相关论文
共 50 条
  • [1] RADIOLABELLING OF NEUROTENSIN AGONIST AND ANTAGONIST WITH 177Lu
    Lungu, V.
    Chiper, D.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2009, 52 : S484 - S484
  • [2] Radiolabeling of neurotensin agonist and antagonist with 177Lu: bioafinity of 177Lu-DOTA-NT and 177Lu-DOTA-SR48692 to neurotensin receptors
    Lungu, Valeria
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 691 - 691
  • [3] Distinct In Vitro Binding Profile of the Somatostatin Receptor Subtype 2 Antagonist [177Lu]Lu-OPS201 Compared to the Agonist [177Lu]Lu-DOTA-TATE
    Mansi, Rosalba
    Plas, Pascale
    Vauquelin, Georges
    Fani, Melpomeni
    PHARMACEUTICALS, 2021, 14 (12)
  • [4] In vitro dose-response comparison of [177Lu]Lu-labelled somatostatin receptor agonist and antagonist
    Tamborino, G.
    De Saint-Hubert, M.
    Struelens, L.
    Dalm, S.
    Ruigrok, E.
    De Jong, M.
    Nonnekens, J.
    Konijnenberg, M. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S83 - S84
  • [5] An estradiol-conjugate for radiolabelling with 177Lu:: an attempt to prepare a radiotherapeutic agent
    Banerjee, S
    Das, T
    Chakraborty, S
    Samuel, G
    Korde, A
    Venkatesh, M
    Pillai, MRA
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (13) : 4315 - 4322
  • [6] 177Lu-DOTATATE: comparative study between 177Lu NRG/Netherlands and 177Lu ORNL/USA
    Caldeira Filho, Jose de Souza
    NUCLEAR MEDICINE AND BIOLOGY, 2010, 37 (06) : 691 - 692
  • [7] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Nanabala, Raviteja
    Pillai, Maroor Raghavan Ambikalmajan
    Gopal, Buvaneswari
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 56 (06) : 313 - 322
  • [8] Preparation of Patient Doses of [177Lu]Lu-DOTATATE and [177Lu]Lu-PSMA-617 with Carrier Added (CA) and No Carrier Added (NCA) 177Lu
    Raviteja Nanabala
    Maroor Raghavan Ambikalmajan Pillai
    Buvaneswari Gopal
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 313 - 322
  • [9] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Heribert Hänscheid
    Philipp E. Hartrampf
    Andreas Schirbel
    Andreas K. Buck
    Constantin Lapa
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 2566 - 2572
  • [10] Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC
    Haenscheid, Heribert
    Hartrampf, Philipp E.
    Schirbel, Andreas
    Buck, Andreas K.
    Lapa, Constantin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (08) : 2566 - 2572
12345